Literature DB >> 2158343

Bradykinin receptors undergo ligand-induced desensitization.

R A Roberts1, W J Gullick.   

Abstract

Bradykinin binds to specific cell surface receptors on Rat13 fibroblasts with a high affinity (2.1 nM). Prolonged exposure of cells to the ligand causes a concentration-dependent decline in surface levels of the 2.1 nM receptor from 40,000 receptors per cell to undetectable levels with a t1/2 of approximately 2 h. The decline occurs in parallel with the appearance of an equal number of lower affinity binding sites (40 nM), suggesting that ligand exposure causes desensitization by an alteration in receptor affinity. The affinity change is characterized by a faster rate of ligand dissociation while the rate of association remains unaltered. The observed desensitization is dependent on the presence of active cellular metabolism since (i) it does not occur in whole cells maintained at 4 degrees C and (ii) membranes prepared from Rat13 cells retain their high-affinity sites at 37 degrees C despite extensive ligand exposure.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2158343     DOI: 10.1021/bi00460a002

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  3 in total

1.  Agonist-promoted homologous desensitization of human airway smooth muscle bitter taste receptors.

Authors:  Kathryn S Robinett; Deepak A Deshpande; Molly M Malone; Stephen B Liggett
Journal:  Am J Respir Cell Mol Biol       Date:  2011-06-03       Impact factor: 6.914

2.  Suppressive effect of distinct bradykinin B2 receptor antagonist on allergen-evoked exudation and leukocyte infiltration in sensitized rats.

Authors:  C Bandeira-Melo; A S Calheiros; P M Silva; R S Cordeiro; M M Teixeira; M A Martins
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

3.  Human bradykinin B2 receptors isolated by receptor-specific monoclonal antibodies are tyrosine phosphorylated.

Authors:  Y J Jong; L R Dalemar; B Wilhelm; N L Baenziger
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.